These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 17427274)

  • 1. MR spectroscopy in patients with intracranial meningiomas.
    Buhl R; Nabavi A; Wolff S; Hugo HH; Alfke K; Jansen O; Mehdorn HM
    Neurol Res; 2007 Jan; 29(1):43-6. PubMed ID: 17427274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Noninvasive evaluation of the malignant potential of intracranial meningiomas performed using proton magnetic resonance spectroscopy.
    Shino A; Nakasu S; Matsuda M; Handa J; Morikawa S; Inubushi T
    J Neurosurg; 1999 Dec; 91(6):928-34. PubMed ID: 10584837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Using ex vivo proton magnetic resonance spectroscopy to reveal associations between biochemical and biological features of meningiomas.
    Pfisterer WK; Nieman RA; Scheck AC; Coons SW; Spetzler RF; Preul MC
    Neurosurg Focus; 2010 Jan; 28(1):E12. PubMed ID: 20043716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single voxel proton MR spectroscopy findings of typical and atypical intracranial meningiomas.
    Demir MK; Iplikcioglu AC; Dincer A; Arslan M; Sav A
    Eur J Radiol; 2006 Oct; 60(1):48-55. PubMed ID: 16844335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Osteopontin predicts the behaviour of atypical meningioma.
    Lin CK; Tsai WC; Lin YC; Hueng DY
    Histopathology; 2012 Jan; 60(2):320-5. PubMed ID: 22211290
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utilization of glutamate/creatine ratios for proton spectroscopic diagnosis of meningiomas.
    Hazany S; Hesselink JR; Healy JF; Imbesi SG
    Neuroradiology; 2007 Feb; 49(2):121-7. PubMed ID: 17086406
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic alterations in the peritumoral brain in cases of meningiomas: 1H-MRS study.
    Chernov MF; Nakaya K; Kasuya H; Kato K; Ono Y; Yoshida S; Nakamura R; Suzuki T; Muragaki Y; Iseki H; Kubo O; Hori T; Takakura K
    J Neurol Sci; 2009 Sep; 284(1-2):168-74. PubMed ID: 19497588
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New observations concerning the interpretation of magnetic resonance spectroscopy of meningioma.
    Yue Q; Isobe T; Shibata Y; Anno I; Kawamura H; Yamamoto Y; Takano S; Matsumura A
    Eur Radiol; 2008 Dec; 18(12):2901-11. PubMed ID: 18641997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipid signal in evaluation of intracranial meningiomas.
    Qi ZG; Li YX; Wang Y; Geng DY; Li KC; Shen TZ; Chen XR
    Chin Med J (Engl); 2008 Dec; 121(23):2415-9. PubMed ID: 19102960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Usefulness of quantitative proton MR spectroscopy in the differentiation of benign and malignant meningioma.
    Yue Q; Isobe T; Shibata Y; Kawamura H; Anno I; Matsumura A
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2011 Dec; 28(6):1103-9. PubMed ID: 22295694
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Meningiomas: new prognostic factors].
    Sanz Esponera J
    An R Acad Nac Med (Madr); 2007; 124(2):319-32; discussion 330-2. PubMed ID: 18069599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo hydrogen-1 magnetic resonance spectroscopy study of human intracranial tumors.
    Luan W; Zhang J
    Chin Med J (Engl); 1998 Jan; 111(1):56-8. PubMed ID: 10322655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MRS study of meningeal hemangiopericytoma and edema: a comparison with meningothelial meningioma.
    Righi V; Tugnoli V; Mucci A; Bacci A; Bonora S; Schenetti L
    Oncol Rep; 2012 Oct; 28(4):1461-7. PubMed ID: 22824994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Malignancy of brain tumors evaluated by proton magnetic resonance spectroscopy (1H-MRS) in vitro.
    Czernicki Z; Horsztyński D; Jankowski W; Grieb P; Walecki J
    Acta Neurochir Suppl; 2000; 76():17-20. PubMed ID: 11449999
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [1H magnetic resonance spectroscopy in intracranial tumors and cerebral ischemia].
    Felber SR
    Radiologe; 1993 Nov; 33(11):626-32. PubMed ID: 8278589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnosing dural metastases: the value of 1H magnetic resonance spectroscopy.
    Bendszus M; Warmuth-Metz M; Burger R; Klein R; Tonn JC; Solymosi L
    Neuroradiology; 2001 Apr; 43(4):285-9. PubMed ID: 11338410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell type-specific fingerprinting of meningioma and meningeal cells by proton nuclear magnetic resonance spectroscopy.
    Florian CL; Preece NE; Bhakoo KK; Williams SR; Noble MD
    Cancer Res; 1995 Jan; 55(2):420-7. PubMed ID: 7812974
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Utility of proton MR spectroscopy in the diagnosis of radiologically atypical intracranial meningiomas.
    Majós C; Alonso J; Aguilera C; Serrallonga M; Coll S; Acebes JJ; Arús C; Gili J
    Neuroradiology; 2003 Mar; 45(3):129-36. PubMed ID: 12684713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pediatric meningiomas an aggressive subset: a clinicopathological and immunohistochemical study.
    Hui M; Uppin MS; Saradhi MV; Sahu BP; Purohit AK; Sundaram C
    J Postgrad Med; 2015; 61(1):32-5. PubMed ID: 25511215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunocytochemical analysis of glucose transporter protein-1 (GLUT-1) in typical, brain invasive, atypical and anaplastic meningioma.
    van de Nes JA; Griewank KG; Schmid KW; Grabellus F
    Neuropathology; 2015 Feb; 35(1):24-36. PubMed ID: 25168354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.